KYONGBO PHARMACEUTICAL CO., LTD. Logo

KYONGBO PHARMACEUTICAL CO., LTD.

Manufactures APIs and finished drugs, offering global CDMO services from development to production.

214390 | KO

Overview

Corporate Details

ISIN(s):
KR7214390007
LEI:
Country:
South Korea
Address:
충청남도 아산시 실옥로 174, 아산시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kyongbo Pharmaceutical Co., Ltd., established in 1987, is a pharmaceutical company specializing in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and finished drug products. The company's portfolio includes general APIs, sterile APIs for cephalosporin and carbapenem injectables, and high-potency APIs for anticancer treatments. It also manufactures finished dosage forms, including solid oral drugs and sterile injectables. In addition to its own product lines, Kyongbo operates as a Contract Development and Manufacturing Organization (CDMO), providing integrated services from early-stage development through commercial cGMP production for a global client base. The company leverages its extensive experience and dedicated research facilities to innovate within the pharma-chemical sector.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-09 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 50.4 KB
2025-09-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 115.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1021.1 KB
2025-07-31 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.0 KB
2025-07-25 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-07-09 00:00
Legal Proceedings Report
[기재정정]주요사항보고서(영업정지)
Korean 13.0 KB
2025-07-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-07-02 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 34.7 KB
2025-07-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 108.5 KB
2025-06-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.6 KB
2025-06-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.6 KB
2025-06-18 00:00
Legal Proceedings Report
[기재정정]주요사항보고서(영업정지)
Korean 13.4 KB
2025-06-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-06-17 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 35.5 KB

Automate Your Workflow. Get a real-time feed of all KYONGBO PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KYONGBO PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KYONGBO PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Idorsia Ltd Logo
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland
IDIA
IGC Pharma, Inc. Logo
Clinical-stage pharma creating Alzheimer's therapies & AI-powered diagnostics.
United States of America
IGC
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea
249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea
003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea
007570
I-Mab Logo
A clinical-stage biopharma developing immuno-oncology agents and bispecific antibodies for cancer.
United States of America
IMAB
ImageneBio, Inc. Logo
A clinical-stage biopharma pioneering therapies for immune & inflammatory diseases.
United States of America
IMA
IM Cannabis Corp. Logo
International producer of medical-grade cannabis for patients and providers in Israel and Germany.
United States of America
IMCC
Immatics N.V. Logo
Develops T-cell redirecting immunotherapies (ACT & TCR Bispecifics) for solid tumor cancers.
United States of America
IMTX
Immix Biopharma, Inc. Logo
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
United States of America
IMMX

Talk to a Data Expert

Have a question? We'll get back to you promptly.